Workflow
Bio-Techne(TECH)
icon
Search documents
Bio-Techne(TECH) - 2020 Q3 - Earnings Call Transcript
2020-05-01 20:59
Bio-Techne Corporation (NASDAQ:TECH) Q3 2020 Earnings Conference Call April 30, 2020 9:00 AM ET Company Participants David Clair – Senior Director, Investor Relations and Corporate Development Chuck Kummeth – Chief Executive Officer Jim Hippel – Chief Financial Officer Conference Call Participants Puneet Souda – Leerink Partners Catherine Schulte – Baird Dan Arias – Stifel Dan Leonard – Wells Fargo Jacob Johnson – Stephens Patrick Donnelly – Citi Paul Knight – Janney Montgomery Scott Alex Nowak – Craig-Hall ...
Bio-Techne(TECH) - 2020 Q2 - Earnings Call Transcript
2020-02-04 19:04
Bio-Techne Corporation (NASDAQ:TECH) Q2 2020 Earnings Conference Call February 4, 2020 9:00 AM ET Company Participants David Clair - Senior Director, Corporate Development Charles Kummeth - President and CEO Jim Hippel - CFO Conference Call Participants Dan Arias - Stifel Catherine Schulte - Baird Jacob Johnson - Stephens John Leonard - Wells Fargo Patrick Donnelly - Citi Alex Nowak - Craig Hallum Partners Operator Good morning and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of ...
Bio-Techne Corporation (TECH) Investor Presentation - Slideshow
2020-01-16 18:17
| --- | --- | --- | --- | --- | --- | --- | --- | |-------|---------------------------------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | WHERE SCIENCE INTERSECTS INNOVATION | | | | | | | | | Corporate Presentation January 2020 | | | | | | | | | | | | | | | | | | | | | | | | | © 2020 Bio-Techne®. All rights reserved. SAFE HARBOR STATEMENT Cautionary Statements This presentation contains "forward-looking s ...
BIO-TECHNE (TECH) Presents At Stifel Healthcare Conference - Slideshow
2019-11-19 20:38
| --- | --- | --- | --- | --- | --- | --- | |-------|---------------|---------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | WHERE SCIENCE INTERSECTS INNOVATION | | | | | | | November 2019 | Corporate Presentation | | | | | | | | | | | | | © 2019 Bio-Techne®. All rights reserved. ANTIBODIES PROTEINS © 2019 Bio-Techne®. All rights reserved. 2 | --- | --- | --- | --- | --- | --- | |-------------------------------------------------------------------------- ...
Bio-Techne(TECH) - 2020 Q1 - Earnings Call Transcript
2019-10-29 16:17
Bio-Techne Corporation (NASDAQ:TECH) Q1 2020 Earnings Conference Call October 29, 2019 9:00 AM ET Company Participants David Clair - Senior Director, Corporate Development Charles Kummeth - President and CEO Jim Hippel - CFO Conference Call Participants Puneet Souda - SVB Leerink Catherine Schulte - Robert W. Baird Unidentified Analyst - Craig-Hallum Capital Group Paul Knight - Janney Montgomery Operator Good morning and welcome to the Bio-Techne Earnings Conference Call for the First Quarter of Fiscal Year ...
Bio-Techne(TECH) - 2019 Q4 - Earnings Call Transcript
2019-08-06 19:39
Bio-Techne Corporation (NASDAQ:TECH) Q4 2019 Earnings Conference Call August 6, 2019 9:00 AM ET Company Participants Chuck Kummeth - CEO Jim Hippel - CFO Conference Call Participants Puneet Souda - SVB Leerink Catherine Schulte - Baird Dan Leonard - Deutsche Bank Patrick Donnelly - Goldman Sachs Alex Nowak - Craig-Hallum Capital Group Paul Knight - Janney Operator Good morning and welcome to the Bio-Techne Earnings Conference Call for the Fourth Quarter of Fiscal Year 2019. At this time, all participants ha ...
Bio-Techne (TECH) Investor Presentation - Slideshow
2019-06-12 19:44
Click to edit Master title style biotechne® Corporate Presentation June 2019 Business Overview B U S I N E S S O V E R V I E W C O R P O R A T E Legacy Revenue At a Glance: | --- | --- | --- | |------------------------------------|-------|-------| | | | | | | | | | President and CEO: Chuck Kummeth | | | | Headquarters: Minneapolis, MN | 25% | | | Number of Employees: ~2,100 | | | | World Wide Presence: 35 Locations | | | | FY2018 Revenues: $643 million | | | | NASDAQ: TECH | 10% | | | Market Cap: ~$7B | | 6 ...
Bio-Techne(TECH) - 2019 Q3 - Earnings Call Transcript
2019-05-01 02:24
Bio-Techne Corp (NASDAQ:TECH) Q3 2019 Earnings Conference Call April 30, 2019 9:00 AM ET Company Participants James Hippel - SVP, Finance & CFO Charles Kummeth - CEO, President & Director Conference Call Participants Puneet Souda - SVB Leerink Catherine Schulte - Robert W. Baird & Co. Michael Sarcone - Deutsche Bank Charles Steinman - Goldman Sachs Group Alexander Nowak - Craig-Hallum Capital Group Operator Good morning, and welcome to Bio-Techne Earnings Conference Call for the third quarter of fiscal year ...
Bio-Techne(TECH) - 2019 Q2 - Earnings Call Transcript
2019-02-05 20:41
Bio-Techne Corp. (NASDAQ:TECH) Q2 2019 Earnings Conference Call February 5, 2019 9:00 AM ET Company Participants Chuck Kummeth - Chief Executive Officer Jim Hippel - Chief Financial Officer Conference Call Participants Daniel Arias - Citigroup Puneet Souda - FCB Leerink Catherine Schulte - Baird Drew Jones - Stephens Dan Leonard - Deutsche Bank Alex Nowak - Craig-Hallum Capital Group Operator Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2019. At ...
Bio-Techne (TECH) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow
2019-01-09 21:03
Click to edit Master title style biotechne® Corporate Presentation January 2019 Safe Harbor Cautionary Statements This presentation contains "forward-looking statements" within the meaning of the federal securities laws. Except for historical information contained herein, the statements in this presentation are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made herein relate to, among other things, future s ...